These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7996383)

  • 41. In vitro studies with sisomicin and gentamicin.
    Shadomy S; Utz CJ; Shadomy HJ
    Chemotherapy; 1976; 22(6):346-52. PubMed ID: 821725
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro evaluation of ciclopirox as an adjuvant for polymyxin B against gram-negative bacteria.
    Kim KS; Kim T; Pan JG
    J Antibiot (Tokyo); 2015 Jun; 68(6):395-8. PubMed ID: 25586022
    [No Abstract]   [Full Text] [Related]  

  • 43. Vanillin selectively modulates the action of antibiotics against resistant bacteria.
    Bezerra CF; Camilo CJ; do Nascimento Silva MK; de Freitas TS; Ribeiro-Filho J; Coutinho HDM
    Microb Pathog; 2017 Dec; 113():265-268. PubMed ID: 29107747
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Membrane-disorganizing property of polymyxin B nonapeptide.
    Lam C; Hildebrandt J; Schütze E; Wenzel AF
    J Antimicrob Chemother; 1986 Jul; 18(1):9-15. PubMed ID: 3019982
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Antibacterial effects of antiseptics in vitro and in an experiment in vivo].
    Ondrovcík P; Bravo C; Votava M
    Epidemiol Mikrobiol Imunol; 1995 May; 44(2):78-80. PubMed ID: 7670805
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The in vitro activity of veterinary antiseptics].
    Maris P
    Ann Rech Vet; 1990; 21(1):49-55. PubMed ID: 2111651
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [In vitro bactericidal effect of cefotetan-aminoside combinations].
    Thabaut A; Meyran M
    Pathol Biol (Paris); 1988 May; 36(5):361-5. PubMed ID: 3043329
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of copper(II), iron(II) sulphate, and vitamin C combinations on the weak antimicrobial activity of (+)-catechin against Staphylococcus aureus and other microbes.
    Holloway AC; Mueller-Harvey I; Gould SW; Fielder MD; Naughton DP; Kelly AF
    Metallomics; 2012 Dec; 4(12):1280-6. PubMed ID: 23138340
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combined activity of clindamycin and gentamicin on Bacteroides fragilis and other bacteria.
    Okubadejo OA; Allen J
    J Antimicrob Chemother; 1975 Dec; 1(4):403-9. PubMed ID: 812858
    [No Abstract]   [Full Text] [Related]  

  • 50. Polymyxin B in Combination with Antimicrobials Lacking In Vitro Activity versus Polymyxin B in Monotherapy in Critically Ill Patients with Acinetobacter baumannii or Pseudomonas aeruginosa Infections.
    Rigatto MH; Vieira FJ; Antochevis LC; Behle TF; Lopes NT; Zavascki AP
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6575-80. PubMed ID: 26259799
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bactericidal activity of cefazedone.
    Dingeldein E
    Arzneimittelforschung; 1979; 29(2a):394-6. PubMed ID: 385008
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of 4-chloro-2,6-bis-(2-hydroxyl-benzyl)-phenol on healing of skin wounds and growth of bacteria.
    Oryan A; Khalafi-Nezhad A; Toloo N; Soltani Rad MN
    J Vet Med A Physiol Pathol Clin Med; 2007 Dec; 54(10):585-91. PubMed ID: 18045344
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Growth media and assay plate material can impact on the effectiveness of cationic biocides and antibiotics against different bacterial species.
    Bock LJ; Hind CK; Sutton JM; Wand ME
    Lett Appl Microbiol; 2018 May; 66(5):368-377. PubMed ID: 29432643
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of polymyxin B nonapeptide on daptomycin permeability and cell surface properties in Pseudomonas aeruginosa, Escherichia coli, and Pasteurella multocida.
    Morris CM; George A; Wilson WW; Champlin FR
    J Antibiot (Tokyo); 1995 Jan; 48(1):67-72. PubMed ID: 7868392
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Action of EDTA-Tris and antimicrobial agent combinations on selected pathogenic bacteria.
    Wooley RE; Jones MS
    Vet Microbiol; 1983 Jun; 8(3):271-80. PubMed ID: 6412426
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical investigation of topical antimicrobials in healthy volunteers.
    Langford JH; Benrimoj S
    Ann Pharmacother; 1997 Jan; 31(1):34-8. PubMed ID: 8997462
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Determining the sensitivity of wound microflora to antiseptics].
    Buianov VM; Rodoman GV; Khrupalov AA; Stetsenko EV; Korotaev AL
    Vestn Khir Im I I Grek; 1990 Oct; 145(10):106-7. PubMed ID: 1964259
    [No Abstract]   [Full Text] [Related]  

  • 58. [Increased antibacterial activity of antibiotics with etonium in vitro].
    Petrunyk IO
    Mikrobiol Z; 2000; 62(4):43-6. PubMed ID: 11421003
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expansion of antibacterial spectrum of xanthorrhizol against Gram-negatives in combination with PMBN and food-grade antimicrobials.
    Kim MS; Kim HR; Kim H; Choi SK; Kim CH; Hwang JK; Park SH
    J Microbiol; 2019 May; 57(5):405-412. PubMed ID: 30796747
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Shigeta S; Takahashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Matsumoto T; Kashitani F; Kaku M; Ooe H; Mochida C
    Jpn J Antibiot; 1998 Feb; 51(2):69-111. PubMed ID: 9575437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.